Daniel S. Goldman sold Genmab AS (NASDAQ: GMAB)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 2 trades in Genmab AS (GMAB) since 2023, all sales, worth an estimated $83K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Genmab AS (NASDAQ: GMAB) on March 31, 2023. Since that trade, GMAB is down -24.15% against the S&P 500 up +88.27%, an outperformance of -112.42%.
Across these filings, Daniel S. Goldman has been a net seller of GMAB. The most recent disclosed GMAB transaction shown was dated July 10, 2023. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Daniel S. Goldman's GMAB trades vs the price
GMAB is down -24.15% since Daniel S. Goldman sold on March 31, 2023, versus +88.27% for the S&P 500.
Performance since this trade
All Daniel S. Goldman GMAB trades
Daniel S. Goldman & GMAB trading FAQ
Is it legal for Daniel S. Goldman to trade Genmab AS (GMAB) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Genmab AS (GMAB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell GMAB?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Genmab AS (GMAB) on March 31, 2023, according to public STOCK Act filings.
How has GMAB performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold GMAB on March 31, 2023, the stock is down -24.15%, versus +88.27% for the S&P 500 over the same period, an outperformance of -112.42%.
How many times has Daniel S. Goldman traded GMAB?
Daniel S. Goldman has disclosed 2 GMAB trades since 2023. Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional GMAB trades?
Quantellect tracks every disclosed congressional trade in Genmab AS (GMAB) on the Genmab AS congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's GMAB tradesAll congressional filings for Genmab ASDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.